153 related articles for article (PubMed ID: 11782474)
1. FOXC1 transcriptional regulation is mediated by N- and C-terminal activation domains and contains a phosphorylated transcriptional inhibitory domain.
Berry FB; Saleem RA; Walter MA
J Biol Chem; 2002 Mar; 277(12):10292-7. PubMed ID: 11782474
[TBL] [Abstract][Full Text] [Related]
2. Regulation of FOXC1 stability and transcriptional activity by an epidermal growth factor-activated mitogen-activated protein kinase signaling cascade.
Berry FB; Mirzayans F; Walter MA
J Biol Chem; 2006 Apr; 281(15):10098-104. PubMed ID: 16492674
[TBL] [Abstract][Full Text] [Related]
3. The wing 2 region of the FOXC1 forkhead domain is necessary for normal DNA-binding and transactivation functions.
Murphy TC; Saleem RA; Footz T; Ritch R; McGillivray B; Walter MA
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2531-8. PubMed ID: 15277473
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analyses of disease-causing missense mutations in the forkhead domain of FOXC1.
Saleem RA; Banerjee-Basu S; Berry FB; Baxevanis AD; Walter MA
Hum Mol Genet; 2003 Nov; 12(22):2993-3005. PubMed ID: 14506133
[TBL] [Abstract][Full Text] [Related]
5. Human p32 is a novel FOXC1-interacting protein that regulates FOXC1 transcriptional activity in ocular cells.
Huang L; Chi J; Berry FB; Footz TK; Sharp MW; Walter MA
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5243-9. PubMed ID: 18676636
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of a novel mutation in the FOXC1 forkhead domain.
Saleem RA; Murphy TC; Liebmann JM; Walter MA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4608-12. PubMed ID: 14578375
[TBL] [Abstract][Full Text] [Related]
7. Essential structural and functional determinants within the forkhead domain of FOXC1.
Saleem RA; Banerjee-Basu S; Murphy TC; Baxevanis A; Walter MA
Nucleic Acids Res; 2004; 32(14):4182-93. PubMed ID: 15299087
[TBL] [Abstract][Full Text] [Related]
8. Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia.
Ito YA; Footz TK; Berry FB; Mirzayans F; Yu M; Khan AO; Walter MA
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3573-9. PubMed ID: 19279310
[TBL] [Abstract][Full Text] [Related]
9. Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1.
Saleem RA; Banerjee-Basu S; Berry FB; Baxevanis AD; Walter MA
Am J Hum Genet; 2001 Mar; 68(3):627-41. PubMed ID: 11179011
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor substrate-3 functions as transcriptional activator in the nucleus.
Kabuta T; Hakuno F; Asano T; Takahashi S
J Biol Chem; 2002 Mar; 277(9):6846-51. PubMed ID: 11724774
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis.
Berry FB; Lines MA; Oas JM; Footz T; Underhill DA; Gage PJ; Walter MA
Hum Mol Genet; 2006 Mar; 15(6):905-19. PubMed ID: 16449236
[TBL] [Abstract][Full Text] [Related]
12. Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors.
Kurooka H; Yokota Y
J Biol Chem; 2005 Feb; 280(6):4313-20. PubMed ID: 15563451
[TBL] [Abstract][Full Text] [Related]
13. Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.
Li D; Wang F; Samuels HH
Mol Cell Biol; 2001 Dec; 21(24):8371-84. PubMed ID: 11713274
[TBL] [Abstract][Full Text] [Related]
14. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
Ayton PM; Chen EH; Cleary ML
Mol Cell Biol; 2004 Dec; 24(23):10470-8. PubMed ID: 15542854
[TBL] [Abstract][Full Text] [Related]
15. FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner.
Berry FB; O'Neill MA; Coca-Prados M; Walter MA
Mol Cell Biol; 2005 Feb; 25(4):1415-24. PubMed ID: 15684392
[TBL] [Abstract][Full Text] [Related]
16. SET-related cell division autoantigen-1 (CDA1) arrests cell growth.
Chai Z; Sarcevic B; Mawson A; Toh BH
J Biol Chem; 2001 Sep; 276(36):33665-74. PubMed ID: 11395479
[TBL] [Abstract][Full Text] [Related]
17. The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.
Perani M; Antonson P; Hamoudi R; Ingram CJ; Cooper CS; Garrett MD; Goodwin GH
J Biol Chem; 2005 Dec; 280(52):42863-76. PubMed ID: 16227627
[TBL] [Abstract][Full Text] [Related]
18. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB.
Lee DK; Kang JE; Park HJ; Kim MH; Yim TH; Kim JM; Heo MK; Kim KY; Kwon HJ; Hur MW
J Biol Chem; 2005 Jul; 280(30):27783-91. PubMed ID: 15917220
[TBL] [Abstract][Full Text] [Related]
19. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders.
Kozlowski K; Walter MA
Hum Mol Genet; 2000 Sep; 9(14):2131-9. PubMed ID: 10958652
[TBL] [Abstract][Full Text] [Related]
20. Analyses of a novel L130F missense mutation in FOXC1.
Ito YA; Footz TK; Murphy TC; Courtens W; Walter MA
Arch Ophthalmol; 2007 Jan; 125(1):128-35. PubMed ID: 17210863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
